Investment
Features
FeesSafety
Academy
More
Pluang+

Ventripoint shifts focus from tech development to commercializing AI echocardiography platform VMS.

Company Fundamentals
09 Oct 2026
Seeking Alpha
View Source
Bullish
Ventripoint shifts focus from tech development to commercializing AI echocardiography platform VMS.

Ventripoint Diagnostics is transitioning from technology development and regulatory approval to commercializing its AI-enhanced echocardiography platform, VMS. This platform provides cardiac volumetric measurements comparable to MRI and is approved in the US, Europe, and Canada, with China approval pending. The company has been building scalable sales, installation, training, and support processes while addressing hospital adoption barriers. The update outlines progress, partnerships, future vision for 2027, and financing plans.

Ventripoint Diagnostics Ltd. is the subject of this update. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 10, 2026 01:11 WIB: of 128 priced US health-sector stocks, 110 rose and 16 fell. Notable movers include HUM at USD 435.00 with a 12.37% increase and 93% buy order activity, MRNA at USD 220.32 with an 11.84% rise and 71% sell order activity, and HRTX at USD 0.40 with a 10.75% gain and 57% sell order activity.

More News

ZenaTech launches AI-powered smart safety glasses Stacklens for field technicians, with pilots in 2027.

ZenaTech launches AI-powered smart safety glasses Stacklens for field technicians, with pilots in 2027.

ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...

Market News
Bullish
3 hours ago
Polkadot (DOT) price surges amid broad altcoin buying, no specific catalyst confirmed

Polkadot (DOT) price surges amid broad altcoin buying, no specific catalyst confirmed

Polkadot (DOT) experienced a notable price surge on October 10, 2026, driven by broad market factors rather than any confirmed project-specific news. The rally appears linked to increased risk appetite, short-covering, and technical breakouts common ...

Market News
Bullish
4 hours ago
Two biotechs and other firms priced IPOs amid cautious market, with more biotechs lined up next week.

Two biotechs and other firms priced IPOs amid cautious market, with more biotechs lined up next week.

Last week saw two biotech companies successfully price their IPOs, alongside a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company. Despite market caution limiting some IPO activity, biotechs remain activ...

Market News
Bullish
4 hours ago
XRP Ledger fixes flaw that could have let attackers create unlimited XRP tokens.

XRP Ledger fixes flaw that could have let attackers create unlimited XRP tokens.

The XRP Ledger patched a critical vulnerability in its payment engine that could have allowed attackers to create and spend XRP beyond the network's 100 billion token supply. The flaw, present in versions 3.4.0 and earlier, was fixed in version 3.4.1...

Protocol Fundamentals
Neutral
4 hours ago
XRP Ledger fixed a 2015 bug that could have created billions of XRP from nothing.

XRP Ledger fixed a 2015 bug that could have created billions of XRP from nothing.

A decade-old bug in the XRP Ledger's payment system could have allowed attackers to create and spend new XRP tokens without funding them, violating the fixed supply of 100 billion XRP. The vulnerability involved a counting error in the ledger's built...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App